Statewide

Maryland Institute for Emergency Medical Services Systems

Current321 dose entries71 drugs19 documentsMDeffective 2026-07-0193% machine-parsed of 321

Maryland Institute for Emergency Medical Services Systems (MD) carries 71 drugs across 321 dose entries in its current published protocol, effective 2026-07-01.

Drugs and doses71

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	650 mg	PO	not captured	standing	page 33
Fever	peds	10–15 mg/kg	PO	not captured	standing	page 33
Mild to moderate pain	adult	650 mg	PO	not captured	standing	page 118
Mild to moderate pain	peds	10–15 mg/kg	PO	not captured	standing	page 118

Activated Charcoal

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 g/kg	PO	not captured	standing	page 212
Other	peds	1 g/kg	PO	not captured	standing	page 212

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	6 mg	IV	not captured	standing	page 223
Narrow-complex tachycardia	peds	0.1 mg/kg	IV	not captured	standing	page 223

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Crush injury	peds	1.25 mg	NEB	not captured	standing	page 114
Hyperkalemia	peds	1.25 mg	NEB	not captured	standing	page 114
Respiratory distress	adult	2 puff	not captured	not captured	standing	page 102
Respiratory distress	adult	2.5 mg	NEB	not captured	standing	page 102
Respiratory distress	peds	1.25 mg	NEB	not captured	standing	page 102
Respiratory distress	peds	2 puff	not captured	not captured	standing	page 102

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	150 mg	IV/IO	not captured	standing	page 60
Atrial fibrillation with RVR	adult	150 mg	IV/IO	not captured	standing	page 60
Atrial fibrillation with RVR	peds	5 mg/kg	IV/IO	not captured	standing	page 60
Atrial fibrillation with RVR	peds	5 mg/kg	IV/IO	not captured	standing	page 60
Wide-complex tachycardia	adult	300 mg	IV/IO	not captured	standing	page 66
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	page 66
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	page 66
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	page 66

Amoxicillin-Clavulanate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 tablet	PO	not captured	standing	page 459
Other	adult	1 tablet	PO	not captured	standing	page 459
Other	peds	10 mg/kg	PO	not captured	standing	page 459
Other	peds	10 mg/kg	PO	not captured	standing	page 459

Antacid

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	15–45 mL	PO	not captured	standing	page 455
Other	adult	15–45 mL	PO	not captured	standing	page 455
Other	adult	15–45 mL	PO	not captured	standing	page 455
Other	adult	15–45 mL	PO	not captured	standing	page 455
Other	adult	15–45 mL	PO	not captured	standing	page 455
Other	peds	15–45 mL	PO	not captured	standing	page 455
Other	peds	15–45 mL	PO	not captured	standing	page 455
Other	peds	15–45 mL	PO	not captured	standing	page 455
Other	peds	15–45 mL	PO	not captured	standing	page 455
Other	peds	15–45 mL	PO	not captured	standing	page 455

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	page 89
STEMI	adult	324 mg	PO	not captured	standing	page 89

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.5–1 mg	IV	not captured	standing	page 56
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	page 56
Nerve agent exposure	adult	2–4 mg	IV/IM	not captured	standing	page 230
Nerve agent exposure	peds	0.02 mg/kg	IV/IM	not captured	standing	page 230
Organophosphate poisoning	adult	2–4 mg	IV/IM	not captured	standing	page 230
Organophosphate poisoning	peds	0.02 mg/kg	IV/IM	not captured	standing	page 230

Azithromycin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	Per MD/DO	PO	not captured	standing	page 459

Buprenorphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	16 mg	SL	not captured	standing	page 415

Caffeine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	200 mg	PO	not captured	standing	page 465
Other	adult	200 mg	PO	not captured	standing	page 465

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	0.5–1 g	IV/IO	not captured	standing	page 231
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV/IO	not captured	standing	page 231
Crush injury	adult	1 g	IV/IO	not captured	standing	page 114
Crush injury	peds	20 mg/kg	IV/IO	not captured	standing	page 114
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	page 114
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	page 114
Hypotension / shock	adult	500 mg	IV/IO	not captured	standing	page 231
Other	adult	0.5–1 g	IV/IO	not captured	standing	page 231
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 231

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	3 g	IV/IO	not captured	standing	page 395
Other	adult	4 mL	NEB	not captured	standing	page 395
Other	peds	4 mL	NEB	not captured	standing	page 395
Other	peds	60 mg/kg	IV/IO	not captured	standing	page 395

Cefazolin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 g	IV/IO	not captured	standing	page 180
Other	peds	500 mg	IV/IO	not captured	standing	page 180
Trauma / hemorrhage	adult	2 g	IV/IO	not captured	standing	page 180
Trauma / hemorrhage	adult	2 g	IV/IO	not captured	standing	page 180
Trauma / hemorrhage	peds	500 mg	IV/IO	not captured	standing	page 180
Trauma / hemorrhage	peds	500 mg	IV/IO	not captured	standing	page 180

Cephalexin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	500 mg	PO	not captured	standing	page 460
Other	adult	500 mg	PO	not captured	standing	page 502
Other	adult	500 mg	PO	not captured	standing	page 502
Other	peds	10 mg/kg	PO	not captured	standing	page 460
Other	peds	10 mg/kg	PO	not captured	standing	page 502
Other	peds	10 mg/kg	PO	not captured	standing	page 502

Cetirizine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	10 mg	PO	not captured	standing	page 454
Allergic reaction	peds	10 mg	PO	not captured	standing	page 454

Cimetidine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	300 mg	PO	not captured	standing	page 455

Ciprofloxacin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	500 mg	PO	not captured	standing	page 459
Other	adult	500 mg	PO	not captured	standing	page 502
Other	adult	500 mg	PO	not captured	standing	page 502

Clindamycin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	300 mg	PO	not captured	standing	page 460
Other	adult	300 mg	PO	not captured	standing	page 460
Other	adult	300 mg	PO	not captured	standing	page 460
Other	peds	10 mg/kg	PO	not captured	standing	page 460
Other	peds	10 mg/kg	PO	not captured	standing	page 460
Other	peds	10 mg/kg	PO	not captured	standing	page 460

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	15 mg	IV/IO/IM	not captured	standing	page 233
Anaphylaxis	peds	0.5 mg/kg	IV/IO/IM	not captured	standing	page 233
Asthma / bronchospasm	adult	15 mg	IV/IM/PO	not captured	standing	page 233
Asthma / bronchospasm	peds	0.5 mg/kg	IV/IM/PO	not captured	standing	page 233
COPD	adult	15 mg	IV/IM/PO	not captured	standing	page 233
Croup	peds	0.5 mg/kg	IV/IM/PO	not captured	standing	page 153
Other	adult	15 mg	IV/IO/IM	not captured	standing	page 233
Other	peds	0.5 mg/kg	IV/IO/IM	not captured	standing	page 233

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV/IO	not captured	standing	page 113
Hypoglycemia	peds	2 mL/kg	IV/IO	not captured	standing	page 113

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	10 mg	IM	not captured	standing	page 236
Nerve agent exposure	peds	0.1 mg/kg	IM	not captured	standing	page 236
Seizure	adult	2.5–10 mg	IV/IM	not captured	standing	page 236
Seizure	peds	0.1 mg/kg	IV/IM	not captured	standing	page 236
Seizure	peds	0.2 mg/kg	PR	not captured	standing	page 236

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	0.25 mg/kg	IV	not captured	standing	page 60
Atrial fibrillation with RVR	adult	0.25 mg/kg	IV	not captured	standing	page 60

Dimenhydrinate

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	50–100 mg	IV/IM/PO	not captured	standing	page 456

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25–50 mg	IV/IM	not captured	standing	page 102
Allergic reaction	peds	1 mg/kg	IV/IM	not captured	standing	page 102
Anaphylaxis	adult	50 mg	IV/IM	not captured	standing	page 105
Anaphylaxis	peds	1 mg/kg	IV/IM	not captured	standing	page 105
Dystonic reaction	adult	25–50 mg	IV/IM	not captured	standing	page 96
Dystonic reaction	peds	1 mg/kg	IV/IM	not captured	standing	page 96

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	2–20 mcg/kg	IV	not captured	standing	page 240
Anaphylaxis	peds	2–20 mcg/kg	IV	not captured	standing	page 240
Cardiogenic shock	adult	2–20 mcg/kg	IV	not captured	standing	page 240
Cardiogenic shock	peds	2–20 mcg/kg	IV	not captured	standing	page 240
Sepsis	adult	2–20 mcg/kg	IV	not captured	standing	page 240
Sepsis	peds	2–20 mcg/kg	IV	not captured	standing	page 240
Trauma / hemorrhage	adult	2–20 mcg/kg	IV	not captured	standing	page 240
Trauma / hemorrhage	peds	2–20 mcg/kg	IV	not captured	standing	page 240

Doxycycline

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	100 mg	PO	not captured	standing	page 459
Other	adult	100 mg	PO	not captured	standing	page 497
Other	adult	200 mg	PO	not captured	standing	page 497
Other	peds	2.2 mg/kg	PO	not captured	standing	page 459
Other	peds	2.2 mg/kg	PO	not captured	standing	page 497
Other	peds	2.2 mg/kg	PO	not captured	standing	page 497

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2.5 mg	IV/IM	not captured	standing	page 96
Agitation	peds	2.5 mg	IV/IM	not captured	standing	page 96
Nausea / vomiting	adult	1.25 mg	IV/IM	not captured	standing	page 116
Nausea / vomiting	adult	1.25 mg	IV/IM	not captured	standing	page 116
Nausea / vomiting	peds	1.25 mg	IV/IM	not captured	standing	page 116
Nausea / vomiting	peds	1.25 mg	IV/IM	not captured	standing	page 116

Emtricitabine And Tenofovir

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	Per MD/DO	PO	not captured	standing	page 459

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	page 102
Anaphylaxis	peds	0.15 mg	IM	not captured	standing	page 102
Bradycardia	adult	2–10 mcg	IV/IO	not captured	standing	page 56
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	page 56
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	page 65
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	page 65
Croup	peds	2.5 mL	NEB	not captured	standing	page 153

Esmolol

Indication	Population	Dose	Route	Repeat	Standing	Source
VF / pulseless VT	adult	0.5 mg/kg	IV/IO	not captured	standing	page 67
VF / pulseless VT	adult	0.5 mg/kg	IV/IO	not captured	standing	page 67

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	1 mcg/kg	IN	not captured	standing	page 119
Severe pain	adult	1 mcg/kg	IV/IO/IM	not captured	standing	page 119
Severe pain	peds	1 mcg/kg	IN	not captured	standing	page 119
Severe pain	peds	1 mcg/kg	IV/IO/IM	not captured	standing	page 119

Fexofenadine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	60 mg	PO	not captured	standing	page 454
Allergic reaction	peds	60 mg	PO	not captured	standing	page 454

Fluorescein Stain

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1 drop	TOP	not captured	standing	page 458
Mild to moderate pain	peds	1 drop	TOP	not captured	standing	page 458

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV	not captured	standing	page 251
Beta-blocker / calcium-channel-blocker overdose	peds	0.5 mg	IV	not captured	standing	page 251
Hypoglycemia	adult	1 mg	IM/IN	not captured	standing	page 113
Hypoglycemia	peds	0.5 mg	IM/IN	not captured	standing	page 113

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2.5 mg	IM	not captured	standing	page 252
Agitation	peds	2.5 mg	IM	not captured	standing	page 252

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 370
Cyanide poisoning	peds	70 mg/kg	IV	not captured	standing	page 370

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	500 mcg	NEB	not captured	standing	page 102
Allergic reaction	peds	250 mcg	NEB	not captured	standing	page 102
Anaphylaxis	adult	500 mcg	NEB	not captured	standing	page 102
Anaphylaxis	peds	250 mcg	NEB	not captured	standing	page 102
Asthma / bronchospasm	adult	500 mcg	NEB	not captured	standing	page 102
Asthma / bronchospasm	adult	500 mcg	NEB	not captured	standing	page 102
Asthma / bronchospasm	peds	250 mcg	NEB	not captured	standing	page 102
Asthma / bronchospasm	peds	250 mcg	NEB	not captured	standing	page 102

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	1 mg/kg	IV/IO	not captured	standing	page 96
Agitation	adult	4 mg/kg	IM	not captured	standing	page 96
Agitation	peds	1 mg/kg	IV/IO	not captured	standing	page 96
Agitation	peds	4 mg/kg	IM	not captured	standing	page 96
Other	adult	1 mg/kg	IV/IO	not captured	standing	page 257
Other	adult	2 mg/kg	IV/IO	not captured	standing	page 257
Other	peds	2 mg/kg	IV/IO	not captured	standing	page 257
Severe pain	adult	0.2 mg/kg	IV/IO	not captured	standing	page 119
Severe pain	adult	0.5 mg/kg	IM/IN	not captured	standing	page 119
Severe pain	peds	0.2 mg/kg	IV/IO	not captured	standing	page 119
Severe pain	peds	0.5 mg/kg	IM/IN	not captured	standing	page 119
Seizure	adult	1 mg/kg	IV/IO	not captured	standing	page 122
Seizure	adult	2 mg/kg	IM/IN	not captured	standing	page 122
Seizure	peds	1 mg/kg	IV/IO	not captured	standing	page 122
Seizure	peds	1 mg/kg	IM/IN	not captured	standing	page 122

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Burns	adult	15 mg	IV	not captured	standing	page 258
Burns	adult	30 mg	IM	not captured	standing	page 258
Burns	peds	0.5 mg/kg	IV	not captured	standing	page 258
Burns	peds	1 mg/kg	IM	not captured	standing	page 258
Other	adult	15 mg	IV	not captured	standing	page 258
Other	adult	30 mg	IM	not captured	standing	page 258
Other	peds	0.5 mg/kg	IV	not captured	standing	page 258
Other	peds	1 mg/kg	IM	not captured	standing	page 258
Mild to moderate pain	adult	15 mg	IV	not captured	standing	page 258
Mild to moderate pain	adult	30 mg	IM	not captured	standing	page 258
Mild to moderate pain	peds	0.5 mg/kg	IV	not captured	standing	page 258
Mild to moderate pain	peds	1 mg/kg	IM	not captured	standing	page 258
Severe pain	adult	15 mg	IV	not captured	standing	page 119
Severe pain	adult	30 mg	IM	not captured	standing	page 119
Severe pain	peds	0.5 mg/kg	IV	not captured	standing	page 119
Severe pain	peds	1 mg/kg	IM	not captured	standing	page 119

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	20 mg	IV/IO	not captured	standing	page 260
Stroke	adult	10 mg	IV/IO	not captured	standing	page 260

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mg/kg	IV/IO	not captured	standing	page 385
Other	adult	20–40 mg	IO	not captured	standing	page 265
Other	peds	10–20 mg	IO	not captured	standing	page 265
Wide-complex tachycardia	adult	1–1.5 mg/kg	IV/IO	not captured	standing	page 264
Wide-complex tachycardia	peds	1 mg/kg	IV/IO	not captured	standing	page 264
VF / pulseless VT	adult	1.5 mg/kg	IV/IO	not captured	standing	page 264
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	page 264

Loperamide

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	4 mg	PO	not captured	standing	page 456
Other	peds	2 mg	PO	not captured	standing	page 456

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	1–2 g	IV/IO	not captured	standing	page 267
Asthma / bronchospasm	adult	1–2 g	IV/IO	not captured	standing	page 267
Asthma / bronchospasm	peds	50 mg/kg	IV/IO	not captured	standing	page 267
Asthma / bronchospasm	peds	50 mg/kg	IV/IO	not captured	standing	page 267
Eclampsia / pre-eclampsia	adult	4 g	IV/IO	not captured	standing	page 267
Eclampsia / pre-eclampsia	peds	4 g	IV/IO	not captured	standing	page 267
Other	adult	4 g	IV/IO	not captured	standing	page 267
Other	peds	4 g	IV/IO	not captured	standing	page 267
Wide-complex tachycardia	adult	2 g	IV/IO	not captured	standing	page 266
Wide-complex tachycardia	peds	25 mg/kg	IV/IO	not captured	standing	page 266
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	page 266
VF / pulseless VT	peds	25 mg/kg	IV/IO	not captured	standing	page 266

Meclizine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	25–50 mg	PO	not captured	standing	page 457

Metoclopramide

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	10–20 mg	IV/IM/PO	not captured	standing	page 456
Nausea / vomiting	peds	0.1 mg/kg	IV/IM/PO	not captured	standing	page 456

Metoprolol Tartrate

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	5 mg	IV/IO	not captured	standing	page 268
Atrial fibrillation with RVR	adult	5 mg	IV/IO	not captured	standing	page 268

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IV/IM	not captured	standing	page 271
Agitation	peds	0.1 mg/kg	IV/IM	not captured	standing	page 271
Alcohol withdrawal	adult	2–2.5 mg	IV	not captured	standing	page 272
Alcohol withdrawal	adult	5 mg	IM/IN	not captured	standing	page 272
Nerve agent exposure	adult	5 mg	IM	not captured	standing	page 271
Other	adult	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 90
Other	adult	0.1 mg/kg	IV	not captured	standing	page 272
Other	adult	5 mg	IV/IM	not captured	standing	page 271
Other	peds	0.05 mg/kg	IV	not captured	standing	page 272
Other	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 90
Other	peds	0.1 mg/kg	IV/IM	not captured	standing	page 271
Procedural sedation	adult	0.1 mg/kg	IV	not captured	standing	page 310
Procedural sedation	adult	0.1 mg/kg	IV	not captured	standing	page 310
Procedural sedation	peds	0.1 mg/kg	IV	not captured	standing	page 310
Procedural sedation	peds	0.1 mg/kg	IV	not captured	standing	page 310
RSI induction	adult	0.1 mg/kg	IV/IM/IN	not captured	standing	page 270
RSI induction	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	page 270
Seizure	adult	0.1 mg/kg	IV/IO	not captured	standing	page 271
Seizure	adult	0.2 mg/kg	IM/IN	not captured	standing	page 271
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	page 271
Seizure	peds	0.2 mg/kg	IM/IN	not captured	standing	page 271

Modafinil

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	200 mg	PO	not captured	standing	page 466

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 274
CHF / pulmonary edema	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 274
Severe pain	adult	0.1 mg/kg	IV/IM	not captured	standing	page 274
Severe pain	peds	0.1 mg/kg	IV/IM	not captured	standing	page 274

Mupirocin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	Per MD/DO	TOP	not captured	standing	page 459
Other	peds	Per MD/DO	TOP	not captured	standing	page 459

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Respiratory distress	adult	2 mg	IN	not captured	standing	page 163
Respiratory distress	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 163
Respiratory distress	peds	0.2–0.25 mg/kg	ET	not captured	standing	page 165
Respiratory distress	peds	2 mg	IN	not captured	standing	page 163

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	page 89
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 150
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 150

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	0.05–2 mcg/kg	IV	not captured	standing	page 419
Hypotension / shock	adult	0.05–2 mcg/kg	IV	not captured	standing	page 419

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4–8 mg	IM	not captured	standing	page 279
Nausea / vomiting	adult	4–8 mg	IM	not captured	standing	page 279
Nausea / vomiting	adult	8 mg	IV	not captured	standing	page 279
Nausea / vomiting	adult	8 mg	ODT	not captured	standing	page 279
Nausea / vomiting	adult	8 mg	IV	not captured	standing	page 279
Nausea / vomiting	adult	8 mg	ODT	not captured	standing	page 279
Nausea / vomiting	peds	0.1 mg/kg	IV	not captured	standing	page 279
Nausea / vomiting	peds	0.1 mg/kg	IM	not captured	standing	page 279
Nausea / vomiting	peds	0.1 mg/kg	IV	not captured	standing	page 279
Nausea / vomiting	peds	0.1 mg/kg	IM	not captured	standing	page 279
Nausea / vomiting	peds	8 mg	ODT	not captured	standing	page 279
Nausea / vomiting	peds	8 mg	ODT	not captured	standing	page 279

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	10–15 g	PO	not captured	standing	page 113
Hypoglycemia	peds	10–15 g	PO	not captured	standing	page 113

Oxycodone

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	5–10 mg	PO	not captured	standing	page 500
Severe pain	peds	0.1 mg/kg	PO	not captured	standing	page 500

Oxymetazoline

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	Two sprays per nare	IN	not captured	standing	page 455
Other	adult	Two sprays per nare	IN	not captured	standing	page 455
Other	peds	Two sprays per nare	IN	not captured	standing	page 455
Other	peds	Two sprays per nare	IN	not captured	standing	page 455
Mild to moderate pain	adult	Two sprays per nare	IN	not captured	standing	page 455
Mild to moderate pain	peds	Two sprays per nare	IN	not captured	standing	page 455

Prednisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	40 mg	PO	not captured	standing	page 462
Asthma / bronchospasm	adult	40 mg	PO	not captured	standing	page 462
COPD	adult	40 mg	PO	not captured	standing	page 462
Other	adult	40 mg	PO	not captured	standing	page 462

Promethazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	25 mg	PO	not captured	standing	page 498
Nausea / vomiting	peds	0.5 mg/kg	PO	not captured	standing	page 498

Proparacaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1–2 drop	not captured	not captured	standing	page 457
Mild to moderate pain	peds	1–2 drop	not captured	not captured	standing	page 457

Pseudoephedrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	30–60 mg	PO	not captured	standing	page 454
Other	adult	30–60 mg	PO	not captured	standing	page 454

Scopolamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	1 mg	TD	not captured	standing	page 457

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	1 mEq/kg	IV/IO	not captured	standing	page 281
Cardiac arrest	peds	1 mEq/kg	IV/IO	not captured	standing	page 281
Crush injury	adult	50 mEq	IV/IO	not captured	standing	page 281
Crush injury	peds	1 mEq/kg	IV/IO	not captured	standing	page 281
Hyperkalemia	adult	50 mEq	IV/IO	not captured	standing	page 281
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	page 281
Other	adult	1 mEq/kg	IV/IO	not captured	standing	page 281
Other	adult	1 mEq/kg	IV/IO	not captured	standing	page 281
Other	peds	1 mEq/kg	IV/IO	not captured	standing	page 281
Other	peds	1 mEq/kg	IV/IO	not captured	standing	page 281

Terbutaline

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.25 mg	IM	not captured	standing	page 283
Other	adult	0.25 mg	IM	not captured	standing	page 283

Tetracaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 drop	not captured	not captured	standing	page 492
Other	peds	2 drop	not captured	not captured	standing	page 492
Mild to moderate pain	adult	1–2 drop	not captured	not captured	standing	page 457
Mild to moderate pain	peds	1–2 drop	not captured	not captured	standing	page 457

Tramadol

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	50–100 mg	PO	not captured	standing	page 463

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	1 g	IV/IO	not captured	standing	page 110
Obstetric hemorrhage	adult	1 g	IV/IO	not captured	standing	page 284
Obstetric hemorrhage	peds	500 mg	IV/IO	not captured	standing	page 284
Trauma / hemorrhage	adult	1 g	IV/IO	not captured	standing	page 284
Trauma / hemorrhage	peds	500 mg	IV/IO	not captured	standing	page 284

Trimethoprim-Sulfamethoxazole

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 DS tab bid	PO	not captured	standing	page 507
Other	adult	1 DS tab bid	PO	not captured	standing	page 507
Other	adult	1 DS tab bid	PO	not captured	standing	page 507
Other	peds	5 mg/kg	PO	every 12 hours	standing	page 507
Other	peds	5 mg/kg	PO	every 12 hours	standing	page 507
Other	peds	5 mg/kg	PO	every 12 hours	standing	page 507

Zaleplon

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10–20 mg	PO	not captured	standing	page 465

Cite this

Maryland Institute for Emergency Medical Services Systems, United States EMS Protocol Census. 321 dose entries, effective 2026-07-01.

https://protoquiz.com/census/agencies/maryland-institute-for-emergency-medical-services-systems/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.